Ticker >

3B Blackbio Dx share price

3B Blackbio Dx Ltd.

BSE: 532067 SECTOR: Pesticides & Agrochemicals  33k   142   22

769.60
+4.40 (0.58%)
BSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 791

Today's Low

₹ 760

52 Week High

₹ 924

52 Week Low

₹ 390

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

577.82 Cr.

Enterprise Value

578.95 Cr.

No. of Shares

0.75 Cr.

P/E

32.76

P/B

2.62

Face Value

₹ 10

Div. Yield

0.32 %

Book Value (TTM)

₹  293.77

CASH

0.9 Cr.

DEBT

2.03 Cr.

Promoter Holding

38.43 %

EPS (TTM)

₹  23.49

Sales Growth

-22.71%

ROE

8.97 %

ROCE

10.81%

Profit Growth

-73.03 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-22.71%
3 Year-3.88%
5 Year-5.07%

Profit Growth

1 Year-73.03%
3 Year52.09%
5 Year32.95%

ROE%

1 Year8.97%
3 Year17.09%
5 Year11.56%

ROCE %

1 Year10.81%
3 Year17.93%
5 Year12.41%

Debt/Equity

0.0838

Price to Cash Flow

351.24

Interest Cover Ratio

14.3588709677419

CFO/PAT (5 Yr. Avg.)

1.08016138655978

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 38.43 0
Sep 2023 38.43 0
Jun 2023 38.43 0
Mar 2023 38.43 0
Dec 2022 38.43 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 52.091037045823% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 5.97379798926916.
  • The company has a good cash flow management; CFO/PAT stands at 1.08016138655978.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 19.7527690101771.

 Limitations

  • The company has shown a poor revenue growth of -3.88414601091748% for the Past 3 years.
  • Company has high debtor days of 426.616719177169.
  • The company has a low EBITDA margin of -4.47432481324273% over the past 5 years.
  • The company is trading at a high PE of 32.76.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 13.64 3.32 2.47 18.57 16.96
Total Expenditure 6.41 3.71 2.44 9.9 7.36
Operating Profit 7.22 -0.39 0.02 8.66 9.6
Other Income 2.88 0.54 0.39 2.75 2.47
Interest 0.05 0.05 0.02 0.04 0.02
Depreciation 0.19 0.09 0.08 0.22 0.2
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.86 0.02 0.32 11.15 11.85
Tax 2.18 0.3 0.08 2.67 2.64
Profit After Tax 7.68 -0.29 0.24 8.48 9.21
Adjusted EPS (Rs) 8.97 -0.38 0.32 9.9 10.75

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 12.09 13.51 14.36 15.52 12
Total Expenditure 11.66 13.75 15.57 16.76 12.93
Operating Profit 0.43 -0.24 -1.21 -1.23 -0.93
Other Income 0.76 1.4 3.72 10.09 4.09
Interest 0.46 0.33 0.23 0.11 0.2
Depreciation 0.29 0.22 0.2 0.29 0.3
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.44 0.61 2.08 8.46 2.65
Tax 0.01 0 0.37 0.46 0.49
Net Profit 0.43 0.61 1.72 8.01 2.16
Adjusted EPS (Rs.) 0.67 0.82 2.29 10.69 2.88

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 6.39 7.49 7.49 7.49 7.49
Total Reserves 9.35 13.29 15.16 16.44 16.73
Borrowings 2.14 1.46 1.02 0.84 0.91
Other N/C liabilities 0.65 0.65 0.62 0.91 0.88
Current liabilities 8.17 5.27 4.6 5.93 3.84
Total Liabilities 26.7 28.17 28.89 31.6 29.86
Assets
Net Block 2.17 1.97 1.98 3.23 3
Capital WIP 0.1 0.2 0.13 0.11 0.09
Intangible WIP 0 0 0 0 0
Investments 1.35 3.6 3.6 3.6 3.6
Loans & Advances 0.14 0.23 0.26 0.27 0.23
Other N/C Assets 0 0 0 0 0
Current Assets 22.94 22.17 22.92 24.4 22.94
Total Assets 26.7 28.17 28.89 31.6 29.86
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.44 0.61 2.08 8.46 2.65
Adjustment 0.75 0.55 0.43 0.4 0.5
Changes in Assets & Liabilities -0.73 -0.06 0.68 -0.71 -1
Tax Paid -0.01 0 -0.4 -0.17 -0.51
Operating Cash Flow 0.45 1.1 2.79 7.98 1.65
Investing Cash Flow -0.08 -2.45 -0.17 -1.52 -0.02
Financing Cash Flow -0.38 1.42 -1.59 -6.31 -2.57
Net Cash Flow -0.01 0.07 1.02 0.14 -0.95

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 38.43 38.43 38.43 38.43 38.43
anamika dubey 0.29 0.29 0.29 0.29 0.29
dhirendra dubey 5.21 5.21 5.21 5.21 5.21
madhulika dubey 0.39 0.39 0.39 0.39 0.39
mahesh kumar upadhyay 0.33 0.33 0.33 0.33 0.33
mithala laboratories priv... 10.93 10.93 10.93 10.93 10.93
mithla dubey 14.12 14.12 14.12 14.12 14.12
nikhil kuber dubey 3.66 3.66 3.66 3.66 3.66
rajesh kumar dubey 0.50 0.50 0.50 0.50 0.50
ram kuber dhirendra kumar... 2.59 2.59 2.59 2.59 2.59
sanjay kumar dubey 0.07 0.07 0.07 0.07 0.07
santosh kumar dubey 0.35 0.35 0.35 0.35 0.35
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 61.57 61.57 61.57 61.57 61.57
amit chander 1.03 1.03 1.03 1.03 1.03
ark global emerging compa... 1.36 1.78 2.16 2.37 2.37
dalmus performance focuse... - - - - 1.18
investor education and pr... 0.50 0.50 - - 0.48
maj navraj singh grewal 2.99 2.99 2.99 2.99 2.99
own infracon private limi... 5.93 5.93 5.93 5.93 5.93
sandeep kapadia - - - 1.13 1.15
shalu aggarwal - - - 1.07 1.33
varun daga 5.99 5.99 5.99 5.99 5.99
investor education and pr... 0.50 - 0.50 0.50 -
lenus finvest private lim... 2.13 2.06 2.06 1.04 -

Annual Reports

Ratings & Research Reports

Company Presentations

  • PresentationQ4FY21 25 Jun 2021
  • PresentationQ3FY24 12 Feb 2024
  • PresentationQ3FY22 11 Feb 2022
  • PresentationQ3FY21 8 Feb 2021
  • PresentationQ2FY24 22 Nov 2023
  • PresentationQ2FY21 5 Nov 2020
  • PresentationQ1FY22 4 Aug 2021
  • PresentationQ1FY21 1 Aug 2020

Company News

3B BlackBio Dx informs about issue of duplicate share certificate13 Mar 2024, 3:39PM 3B Blackbio Dx - Quaterly Results9 Feb 2024, 2:30PM 3B Blackbio Dx - Quaterly Results9 Feb 2024, 2:30PM 3B Blackbio Dx - Quaterly Results9 Feb 2024, 2:30PM 3B Blackbio Dx’s Agro-chemical division receives export order worth Rs 1.59 crore 11 Jan 2024, 10:30AM Kilpest India informs about disclosure 13 Oct 2023, 10:26AM Kilpest India informs about annual general meeting29 Aug 2023, 4:27PM Kilpest India informs about press release26 Aug 2023, 3:14PM Kilpest India - Quaterly Results11 Aug 2023, 2:40PM Kilpest India - Quaterly Results11 Aug 2023, 2:40PM Kilpest India informs about confirmation certificate6 Jul 2023, 5:18PM Kilpest India informs about analyst meet20 Jun 2023, 5:07PM Kilpest India - Quaterly Results29 May 2023, 2:45PM Kilpest India - Quaterly Results14 Feb 2023, 2:20PM Kilpest India informs about closure of trading window30 Dec 2022, 3:51PM Kilpest India’s arm signs non-binding LoI to acquire 100% shares of European based company30 Nov 2022, 9:49AM Kilpest India’s arm bags export order 18 Aug 2022, 3:43PM Kilpest India - Quaterly Results10 Aug 2022, 2:47PM Kilpest India informs about disclosure of related party transactions7 Jun 2022, 4:54PM Kilpest India - Quaterly Results27 May 2022, 2:38PM Kilpest India’s arm completes acquisition of 70% stake in HS Biolabs 29 Mar 2022, 11:57AM Kilpest India informs about investor's presentation9 Feb 2022, 4:43PM Kilpest India - Quaterly Results9 Feb 2022, 2:38PM Kilpest India - Quaterly Results9 Feb 2022, 2:38PM Kilpest India - Quaterly Results9 Feb 2022, 2:38PM Kilpest India informs about proceedings of 49th AGM23 Sep 2021, 3:49PM Kilpest India informs about business update 1 Jun 2021, 3:45PM Kilpest India sells 16,54,000 Covid19 RT-PCR test kits in April 20213 May 2021, 10:13AM Kilpest India sells 2,67,200 COVID-19 RTPCR tests in February 20212 Mar 2021, 11:46AM Kilpest India sells 4.93 lakh COVID-19 RT-PCR Tests in January2 Feb 2021, 10:09AM Kilpest India sells 7.82 lakh COVID-19 RT-PCR Tests in December2 Jan 2021, 10:47AM Kilpest India informs about demise of chairman cum MD 7 Dec 2020, 10:18AM Kilpest India informs about business updates1 Dec 2020, 4:09PM Kilpest India sells 6.10 lakh COVID-19 RT-PCR Tests in November 1 Dec 2020, 3:49PM Kilpest India sells 9.09 lakh COVID-19 tests in October3 Nov 2020, 11:42AM Kilpest India’s arm extends agreement with HS Biolabs Manchestor 12 Oct 2020, 9:31AM Kilpest India sells 8.68 lakh Covid-19 RT-PCR tests in September3 Oct 2020, 10:30AM Kilpest India sells 4,22,000 Covid-19 RT-PCR tests in August3 Sep 2020, 4:32PM Kilpest India sells 6,66,000 Covid19 test kit in June3 Jul 2020, 3:17PM Kilpest India gets USFDA’s grant for multiplex real-time PCR test19 Jun 2020, 4:31PM Kilpest India bags multiple orders for coronavirus test kit from HITES 11 Jun 2020, 9:21AM Kilpest India informs about board meeting 8 Jun 2020, 10:31AM

3B Blackbio Dx Stock Price Analysis and Quick Research Report. Is 3B Blackbio Dx an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). 3B Blackbio Dx has a PE ratio of 32.7582757637284 which is high and comparatively overvalued .

  • Share Price: - The current share price of 3B Blackbio Dx is Rs 769.6. One can use valuation calculators of ticker to know if 3B Blackbio Dx share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. 3B Blackbio Dx has ROA of 7.02810003416912 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. 3B Blackbio Dx has a Current ratio of 5.97379798926916 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. 3B Blackbio Dx has a ROE of 8.97073514171369 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. 3B Blackbio Dx has a D/E ratio of 0.0838 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. 3B Blackbio Dx has an Inventory turnover ratio of 4.2084290650157 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - 3B Blackbio Dx has reported revenue growth of -22.7108162082072 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of 3B Blackbio Dx for the current financial year is -7.78072281122892 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for 3B Blackbio Dx is Rs 2.5 and the yield is 0.3227 %.

Last Updated on:
Brief about 3B Blackbio Dx
X